Cargando…
In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization
The aberrant expression of aldo keto reductases (AKR1B1 & AKR1B10) has been extensively studied in different types of cancer especially the colon cancer but a very few studies have yet been reported regarding the discovery of inhibitors for the treatment of colon cancer by targeting these isozym...
Autores principales: | Ejaz, Syeda Abida, Saeed, Amna, Birmani, Pervez Rashid, Katubi, Khadijah Mohammedsalaeh, Elqahtani, Zainab Mufarreh, Al-Buriahi, M. S., Ujan, Rabail, Siddique, Farhan, Ahmed, Samia ben, Alrowaili, Z. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612481/ https://www.ncbi.nlm.nih.gov/pubmed/36301939 http://dx.doi.org/10.1371/journal.pone.0271602 |
Ejemplares similares
-
Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012) -
Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012) -
AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021) -
AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015) -
Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer
por: Saeed, Amna, et al.
Publicado: (2022)